Sernaz V1 Tablet VT
By Sernaz
1 Tablet VT in a Strip

Composition
Sertaconazole(500mg)

Manufacturer - Canbro Healthcare
plot no.374,phase 3,sector 3,industrial area, hsiidc, karnal, haryana 132001

Expires on or after
January, 2026

liver
Caution should be taken while using Sernaz V1 Tablet VT if you have liver issues. It is important to monitor your liver function closely while taking this medication. Consult your doctor immediately if you experience any signs of liver problems such as yellowing of the skin or eyes, dark urine, or persistent nausea. It is advisable to avoid alcohol consumption while on Sernaz V1 Tablet VT, as it may further impact liver function. Regular liver function tests may be recommended by your healthcare provider while you are using this medication.

kidney
No interaction found/established regarding kidney issues with Sernaz V1 Tablet VT.

alcohol
No interaction has been found between Sernaz V1 Tablet VT and alcohol. It is recommended to consult your doctor regarding alcohol consumption while taking this medication.

driving
No interaction found with driving and Sernaz V1 Tablet VT. It is safe to drive while taking this medication.

pregnancy
Sernaz V1 Tablet VT may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
Sernaz V1 Tablet VT is likely safe to use when breastfeeding. Limited data indicates minimal risk to the baby.
Habit Forming | No |
Chemical Class | Imidazole Derivative |
Therapeutic Class | DERMA |
Action Class | Fungal ergosterol synthesis inhibitor |
₹163.8
₹182
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025